IGF2BP3 and breast carcinoma: Samanta et al. (42) reported that IGF2BP3 bound to mRNA of breast cancer resistance protein (BCRP; also known as ABCG2), a type of ATP-binding cassette (ABC) transporter and a major effector of drug resistance, thereby modulating its expression and promoting drug resistance of breast cancer cells (42).